查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714320

皮膚病治療市場－全球產業規模、佔有率、趨勢、機會與預測，按應用、藥物類別、地區和競爭情況細分，2020-2030 年

Dermatological Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Application, By Drug Class, By Region, & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年皮膚病治療市場價值為 218 億美元，預計到 2030 年將達到 352.5 億美元，複合年成長率為 8.30%。該市場涵蓋影響皮膚、頭髮、指甲和黏膜的疾病的診斷和治療，包括痤瘡和濕疹等常見疾病，以及牛皮癬和皮膚癌等嚴重疾病。由於皮膚病患病率不斷上升、人們對皮膚健康的認知不斷提高以及生物製劑和個人化醫療技術的進步，對皮膚病治療的需求正在上升。隨著全球人口老化和美學問題的日益突出，市場對醫療和美容皮膚療法的興趣日益濃厚。可支配收入的增加，特別是在新興市場，也使得人們能夠更廣泛地獲得皮膚病治療。製藥創新和數位健康趨勢將重塑皮膚病的診斷和治療方式，推動該行業的持續成長。

市場概覽
預測期 2026-2030
2024年市場規模 218億美元
2030年市場規模 352.5億美元
2025-2030 年複合年成長率 8.30%
成長最快的領域 抗感染藥物
最大的市場 北美洲

關鍵市場促進因素

皮膚病盛行率上升

主要市場挑戰

通用競爭

主要市場趨勢

個人化醫療

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：皮膚病治療市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依用途分類（脫髮、皰疹、牛皮癬、酒渣鼻、異位性皮膚炎、其他）
    • 依藥物類別（抗感染藥、皮質類固醇、抗青春痘藥、鈣調磷酸酶抑制劑、維他命A酸類藥物、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美皮膚病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲皮膚病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太皮膚病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲皮膚病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲皮膚病治療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球皮膚病治療市場：SWOT 分析

第 14 章：競爭格局

  • Abbvie Inc. (Allergan PLC)
  • Almirall SA
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company.

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16103

The Dermatological Therapeutics Market was valued at USD 21.80 billion in 2024 and is projected to reach USD 35.25 billion by 2030, growing at a CAGR of 8.30%. This market encompasses the diagnosis and treatment of conditions affecting the skin, hair, nails, and mucous membranes, including common ailments like acne and eczema, as well as serious diseases such as psoriasis and skin cancer. Demand for dermatological treatments is rising due to the growing prevalence of skin disorders, increasing awareness around skin health, and technological advances in biologics and personalized medicine. As the global population ages and aesthetic concerns gain prominence, the market is experiencing heightened interest in both medical and cosmetic skin therapies. Expanding disposable incomes, particularly in emerging markets, are also enabling broader access to dermatological care. Pharmaceutical innovations and digital health trends are poised to reshape how dermatological conditions are diagnosed and managed, driving sustained growth in the sector.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 21.80 Billion
Market Size 2030USD 35.25 Billion
CAGR 2025-20308.30%
Fastest Growing SegmentAnti-infectives
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Skin Disorders

The increasing global burden of skin diseases is a primary driver of the Dermatological Therapeutics Market. Skin disorders affect approximately 1.8 billion people worldwide, with estimates suggesting that 30% to 70% of the population experiences some form of dermatological condition at any given time. This widespread prevalence underscores a strong, sustained demand for effective skin treatments. Common conditions such as acne, eczema, psoriasis, atopic dermatitis, rosacea, and various infections are becoming more frequent across all age groups. This expanding patient pool presents a significant opportunity for pharmaceutical companies to develop and market innovative dermatological solutions. Additionally, growing awareness of skin health, driven by social media and increasing focus on aesthetics, further boosts demand for both therapeutic and cosmetic dermatology products. The persistent rise in skin disease incidence makes dermatology one of the most essential and dynamic sectors in healthcare, reinforcing its critical role in global medical infrastructure.

Key Market Challenges

Generic Competition

Generic competition poses a significant challenge to branded pharmaceutical companies operating in the dermatological therapeutics space. Once the patent protection for a drug expires, generic alternatives enter the market, often at significantly lower prices. This price disparity leads to erosion of market share and revenue for original branded products. The transition to generics intensifies pricing pressures, driving down profit margins and fragmenting the market with numerous similar products. Healthcare providers and insurers increasingly favor generics to reduce treatment costs, further impacting demand for branded therapies. For patients and dermatologists, a growing array of generic options can create confusion and complicate prescribing decisions. As the volume of generics increases, innovation may slow due to reduced financial incentives for R&D in new dermatological treatments, challenging companies to maintain competitiveness in a cost-sensitive environment.

Key Market Trends

Personalized Medicine

Personalized medicine is reshaping the landscape of dermatological therapeutics by offering targeted, individualized treatment approaches based on a patient's genetic profile, biomarkers, and disease characteristics. Advances in genomics enable the identification of genetic markers linked to specific skin conditions, such as psoriasis or melanoma, leading to tailored therapeutic interventions. Biomarker analysis allows dermatologists to predict patient responses to certain drugs and monitor disease progression more accurately. The use of biologics and small molecule inhibitors designed to target specific disease pathways has significantly improved outcomes for patients with severe dermatological conditions. Additionally, customized topical formulations-developed in collaboration with compounding pharmacies-address individual needs related to skin type and sensitivities. Personalized medicine also enhances risk stratification and prevention strategies for skin cancers and chronic inflammatory skin diseases. This trend is driving better clinical results, minimizing side effects, and marking a shift toward more effective and proactive dermatological care.

Key Market Players

  • Abbvie Inc. (Allergan PLC)
  • Almirall SA
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Galderma SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Bristol-Myers Squibb Company

Report Scope:

In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatological Therapeutics Market, By Application:

  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Atopic Dermatitis
  • Other

Dermatological Therapeutics Market, By Drug Class:

  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Other

Dermatological Therapeutics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.

Available Customizations:

Global Dermatological Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Dermatological Therapeutics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Other)
    • 5.2.2. By Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Dermatological Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Drug Class
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermatological Therapeutics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Drug Class
    • 6.3.2. Canada Dermatological Therapeutics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Drug Class
    • 6.3.3. Mexico Dermatological Therapeutics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Drug Class

7. Europe Dermatological Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Drug Class
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermatological Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Drug Class
    • 7.3.2. United Kingdom Dermatological Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Drug Class
    • 7.3.3. Italy Dermatological Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Drug Class
    • 7.3.4. France Dermatological Therapeutics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Drug Class
    • 7.3.5. Spain Dermatological Therapeutics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Drug Class

8. Asia-Pacific Dermatological Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Drug Class
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Dermatological Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Drug Class
    • 8.3.2. India Dermatological Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Drug Class
    • 8.3.3. Japan Dermatological Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Drug Class
    • 8.3.4. South Korea Dermatological Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Drug Class
    • 8.3.5. Australia Dermatological Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Drug Class

9. South America Dermatological Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Drug Class
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Dermatological Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Drug Class
    • 9.3.2. Argentina Dermatological Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Drug Class
    • 9.3.3. Colombia Dermatological Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Drug Class

10. Middle East and Africa Dermatological Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Drug Class
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Dermatological Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Drug Class
    • 10.3.2. Saudi Arabia Dermatological Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Drug Class
    • 10.3.3. UAE Dermatological Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Drug Class

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Dermatological Therapeutics Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Abbvie Inc. (Allergan PLC)
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Almirall SA
  • 14.3. Amgen Inc.
  • 14.4. Bausch Health Companies Inc.
  • 14.5. Galderma SA
  • 14.6. GlaxoSmithKline PLC
  • 14.7. Johnson & Johnson
  • 14.8. Novartis AG
  • 14.9. Pfizer Inc.
  • 14.10.Bristol-Myers Squibb Company.

15. Strategic Recommendations

16. About Us & Disclaimer